<DOC>
	<DOCNO>NCT01100047</DOCNO>
	<brief_summary>This study Japanese healthy volunteer determine safety tolerability compound , AZD5069 . It also assess body handle drug respond drug follow single multiple dos 11 day .</brief_summary>
	<brief_title>Japanese Single Multiple Ascending Dose ( JSMAD ) , Safety , Tolerability , Pharmacokinetics ( PK ) Pharmacodynamics ( PD ) Study AZD5069</brief_title>
	<detailed_description />
	<criteria>Japanese subject suitable vein cannulation repeat venepuncture . Have body mass index ( BMI ) 17 27 kg/m2 body weight 45 80 kg Male subject willing use barrier contraception ie , condom spermicide , first day dose 3 month last dose investigational product History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness/infection medical/surgical procedure trauma , judge Principal Investigator , within 4 week first administration investigational product . Any clinically significant abnormality clinical chemistry , haematology urinalysis judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japanese healthy volunteer</keyword>
	<keyword>AZD5069</keyword>
</DOC>